A 24-week treatment strategy with pegylated interferon/ribavirin in HIV/hepatitis C virus genotype 3-coinfected patients who achieved a rapid virologic response results in a high sustained virologic response rate.
Journal article published in 2013 by
A. Rivero Juarez,
López Cortés Lf 
,
A. Camacho,
Mira Ja,
F. Téllez,
M. Marquez,
D. Merino,
Pineda Ja,
A. Rivero,
part of the Sociedad Andaluza de Enfermedades Infecciosas
,
A. Camacho,
Mira Ja,
F. Téllez,
M. Marquez,
D. Merino,
Pineda Ja,
A. Rivero,
part of the Sociedad Andaluza de Enfermedades Infecciosas
